FiercePharma: Pfizer's
6-Dose-Per-Vial OK Boosts Its Supply Numbers. The Catch? Special Syringes Are
Required
When pharmacists discovered a sixth dose could be pulled from vials of Pfizer
and BioNTech’s vaccine, rather than the original five, it looked like a
solution to supply-constrained vaccine rollouts. But now that the FDA has
approved that tactic, Pfizer's counting those extra doses toward its
established orders, The New York Times reports—which means it won't help boost
immediate supplies. In fact, it might actually cut them. (Kansteiner, 1/25)
No comments:
Post a Comment